User profiles for Júlia Perera-Bel

Júlia Perera-Bel

Bioinformatics Unit, MARGenomics & GRIB, IMIM
Verified email at imim.es
Cited by 497

Large variability of bathypelagic microbial eukaryotic communities across the world's oceans

…, CR Giner, R Logares, J Perera-Bel… - The ISME …, 2016 - academic.oup.com
In this work, we study the diversity of bathypelagic microbial eukaryotes (0.8–20 μm) in the
global ocean. Seawater samples from 3000 to 4000 m depth from 27 stations in the Atlantic, …

[HTML][HTML] Explaining decisions of graph convolutional neural networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer

H Chereda, A Bleckmann, K Menck, J Perera-Bel… - Genome medicine, 2021 - Springer
Background Contemporary deep learning approaches show cutting-edge performance in a
variety of complex prediction tasks. Nonetheless, the application of deep learning in …

Genomic predictors of good outcome, recurrence, or progression in high-grade t1 non–muscle-invasive bladder cancer

J Bellmunt, J Kim, B Reardon, J Perera-Bel, A Orsola… - Cancer research, 2020 - AACR
Detailed genetic analyses of HGT1 bladder tumors identify features that correlate with outcome,
eg, high mutational burden, ERCC2 mutations, and high APOBEC-A/ERCC2 mutation …

[HTML][HTML] From somatic variants towards precision oncology: evidence-driven reporting of treatment options in molecular tumor boards

J Perera-Bel, B Hutter, C Heining, A Bleckmann… - Genome medicine, 2018 - Springer
Background A comprehensive understanding of cancer has been furthered with technological
improvements and decreasing costs of next-generation sequencing (NGS). However, the …

[HTML][HTML] The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer

LM Boll, J Perera-Bel, A Rodriguez-Vida, O Arpí… - Scientific Reports, 2023 - nature.com
Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment and can result in
complete remissions even at advanced stages of the disease. However, only a small fraction of …

PI3K: A master regulator of brain metastasis‐promoting macrophages/microglia

…, A Wolff, S Seitz, A Wachter, J PereraBel… - Glia, 2018 - Wiley Online Library
Mutations and activation of the PI3K signaling pathway in breast cancer cells have been
linked to brain metastases. However, here we describe that in some breast cancer brain …

[HTML][HTML] Circulating microRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection

…, M Clarós, L Nonell, J Perera-Bel… - Scientific Reports, 2022 - nature.com
One of the hallmarks of SARS-CoV-2 infection is an induced immune dysregulation, in
some cases resulting in cytokine storm syndrome and acute respiratory distress syndrome (ARDS)…

[HTML][HTML] Dynamics of gene expression profiling and identification of high-risk patients for severe COVID-19

…, M Bódalo Torruella, G Abelenda-Alonso, J Perera-Bel… - Biomedicines, 2023 - mdpi.com
The clinical manifestations of SARS-CoV-2 infection vary widely, from asymptomatic infection
to the development of acute respiratory distress syndrome (ARDS) and death. The host …

[HTML][HTML] Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer

…, N Gallarín, M Lorenzo, D López, J Perera-Bel… - Virchows Archiv, 2023 - Springer
The impact of tumor focality on prostate cancer (PCa) prognosis has been addressed in
several studies with conflicting results. Tumor foci from multifocal (MF) PCa can show highly …

Pre-existing tumor host immunity characterization in resected non-small cell lung cancer

…, D Casadevall, S Clavé, B Bellosillo, J Perera-Bel… - Lung Cancer, 2023 - Elsevier
Introduction Neoadjuvant and adjuvant immune checkpoint blockade (ICB) have recently
become standard of care in resectable non-small cell lung cancer (NSCLC). Yet, biomarkers …